IBDEI1CZ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23092,0)
 ;;=D86.85^^87^991^42
 ;;^UTILITY(U,$J,358.3,23092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23092,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,23092,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,23092,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,23093,0)
 ;;=D86.83^^87^991^40
 ;;^UTILITY(U,$J,358.3,23093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23093,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,23093,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,23093,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,23094,0)
 ;;=D84.1^^87^991^16
 ;;^UTILITY(U,$J,358.3,23094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23094,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,23094,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,23094,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,23095,0)
 ;;=D81.810^^87^991^5
 ;;^UTILITY(U,$J,358.3,23095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23095,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,23095,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,23095,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,23096,0)
 ;;=E88.01^^87^991^2
 ;;^UTILITY(U,$J,358.3,23096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23096,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,23096,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,23096,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,23097,0)
 ;;=J09.X1^^87^991^25
 ;;^UTILITY(U,$J,358.3,23097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23097,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,23097,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,23097,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,23098,0)
 ;;=J09.X2^^87^991^26
 ;;^UTILITY(U,$J,358.3,23098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23098,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,23098,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,23098,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,23099,0)
 ;;=J09.X3^^87^991^27
 ;;^UTILITY(U,$J,358.3,23099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23099,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,23099,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,23099,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,23100,0)
 ;;=J09.X9^^87^991^28
 ;;^UTILITY(U,$J,358.3,23100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23100,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,23100,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,23100,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,23101,0)
 ;;=J44.9^^87^991^14
 ;;^UTILITY(U,$J,358.3,23101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23101,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,23101,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,23101,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,23102,0)
 ;;=J44.1^^87^991^12
 ;;^UTILITY(U,$J,358.3,23102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23102,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,23102,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,23102,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,23103,0)
 ;;=J42.^^87^991^10
 ;;^UTILITY(U,$J,358.3,23103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23103,1,3,0)
 ;;=3^Bronchitis,Unspec Chronic
 ;;^UTILITY(U,$J,358.3,23103,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,23103,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,23104,0)
 ;;=J43.9^^87^991^22
 ;;^UTILITY(U,$J,358.3,23104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23104,1,3,0)
 ;;=3^Emphysema,Unspec
 ;;^UTILITY(U,$J,358.3,23104,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,23104,2)
 ;;=^5008238
